DISEASE INDICATIONS:Risk of cardiovascular events

MANUFACTURER:Novartis

USAGE:Oral

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Entresto is a prescription medication used for the treatment of heart failure with reduced ejection fraction (HFrEF). It is a combination drug that contains two active ingredients, sacubitril and valsartan. The medication helps lower blood pressure and reduce the workload on the heart.